Author: World Health Organization
A paucity of scientific evidence exists on how to best treat pregnant or breastfeeding women with suspected or confirmed Ebola virus disease (EVD). Historical reports suggest that, among women who acquire EVD during pregnancy, there is increased mortality and morbidity, and a near 100% rate of adverse pregnancy outcomes. To save the lives of mothers and their babies, mitigate complications, and limit the spread of disease, it is critical that recommendations are made on the prevention, treatment, and surveillance of women who are exposed to EVD, acquire EVD during pregnancy or breastfeeding, or survive EVD with ongoing pregnancies. These guidelines are the first to provide such recommendations.
This website is made possible by the support of the American People through the United States Agency for International Development (USAID) under the READY initiative. READY (not an acronym) is supported by USAID’s Bureau for Democracy, Conflict, and Humanitarian Assistance, Office of U.S. Foreign Disaster Assistance (OFDA) and is led by Save the Children in partnership with the Johns Hopkins Center for Humanitarian Health, the Johns Hopkins Center for Communication Programs, UK-Med, EcoHealth Alliance, and Mercy Malaysia. The contents of this website are the sole responsibility of Save the Children. The information provided on this website does not necessarily reflect the views of USAID, any or all consortium partners, or the United States Government, and is not official U.S. Government information.